CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 27 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,139,000 | -10.9% | 6,138,000 | +3.5% | 0.02% | -8.7% |
| Q4 2017 | $8,009,000 | -59.6% | 5,930,000 | -53.8% | 0.02% | -60.3% |
| Q3 2017 | $19,835,000 | -35.9% | 12,828,000 | -29.7% | 0.06% | -37.0% |
| Q2 2017 | $30,967,000 | +68.1% | 18,243,000 | +28.0% | 0.09% | +67.3% |
| Q1 2017 | $18,417,000 | +207.3% | 14,249,000 | +298.1% | 0.06% | +205.6% |
| Q3 2015 | $5,993,000 | – | 3,579,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 43,295,000 | $29,665,000 | 1.82% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,747,000 | 1.38% |
| Baker Brothers Advisors | 129,300,000 | $87,801,000 | 0.93% |
| Castle Creek Arbitrage, LLC | 5,500,000 | $3,755,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 14,300,000 | $9,730,000 | 0.28% |
| Verition Fund Management LLC | 1,966,000 | $1,343,000 | 0.22% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 11,625,000 | $7,960,000,000 | 0.15% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 6,000,000 | $4,106,000 | 0.12% |
| PFM Health Sciences, LP | 4,747,000 | $3,243,000 | 0.10% |
| ARROWGRASS CAPITAL PARTNERS (US) LP | 11,500 | $3,568,000 | 0.04% |